Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Leo Pharma validates psoriasis target from Switch Biotech

Feb. 7, 2003

Improvement of hyperandrogenic alopecia in women after 1-year treatment with flutamide

Feb. 5, 2003

First biologic therapy for psoriasis approved by FDA

Feb. 4, 2003

BioTransplant and Catholic University of Louvain attempt to resolve dispute regarding MEDI-507

Feb. 4, 2003

Catholic University of Louvain to terminate agreement with BioTransplant

Feb. 3, 2003

Toray and Fujisawa to codevelop TRK-820 in Europe

Feb. 3, 2003

MBI-594AN enters phase IIb for treatment of acne

Jan. 31, 2003

Naltrexone well tolerated and effective in pruritus caused by cholestasis

Jan. 28, 2003

Two courses of alefacept evaluated in patients with chronic plaque psoriasis

Jan. 24, 2003

QRX-101 phase II trial in psoriasis cleared to begin

Jan. 24, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...